The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Review of the Endocannabinoid System
Open accessAbstract
The endocannabinoid system (ECS) is a widespread neuromodulatory network involved both in the developing CNS as well as playing a major role in tuning many cognitive and physiological processes. The ECS is composed of endogenous cannabinoids, cannabinoid receptors and the enzymes responsible for the synthesis and degradation of endocannabinoids. In addition to its endogenous roles, cannabinoid receptors are the primary target of Δ9-tetrahydrocannabinol (THC), the intoxicating component of cannabis. In this review, we will summarize our current understanding of the ECS. We will start with a description of ECS components and their role in synaptic plasticity and neurodevelopment, and then discuss how phytocannabinoids and other exogenous compounds may perturb the ECS, emphasizing examples relevant to psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citation2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Non-muscle myosin II takes centre stage in cell adhesion and migration
Vicente-Manzanares, M., Ma, X., Adelstein, R. S., & Horwitz, A. R. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2786 · Cited by 2,032
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Groce, E. (2018) · Journal of Medical Regulation · doi:10.30770/2572-1852-104.4.32 · Cited by 1,330
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30048-3 · Cited by 875
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
Gerdeman, G. L., Ronesi, J., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Nomura, D. K., Morrison, B. E., Blankman, J. L., Long, J. Z., Kinsey, S. G., Marcondes, M. C. G., Ward, A. M., Hahn, Y. K., Lichtman, A. H., Conti, B., et al. (2011) · Science · doi:10.1126/science.1209200 · Cited by 727
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Robbe, D., Kopf, M., Remaury, A., Bockaert, J., & Manzoni, O. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122149199 · Cited by 631
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Self-citationCB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Self-citationMitochondrial CB1 receptors regulate neuronal energy metabolism
Bénard, G., Massa, F., Puente, N., Lourenço, J., Bellocchio, L., Soria-Gómez, E., Matias, I., Delamarre, A., Metna-Laurent, M., Cannich, A., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3053 · Cited by 588
Endocannabinoids Mediate Neuron-Astrocyte Communication
Navarrete, M., & Araque, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.029 · Cited by 581
Molecular Targets of Cannabidiol in Neurological Disorders
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 578
Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity
Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., et al. (2007) · Science · doi:10.1126/science.1137406 · Cited by 551
Self-citationCannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 527
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Self-citationHuestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473
Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.021 · Cited by 472
Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt181 · Cited by 470
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H.-Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 470
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., Bodor, A. L., Muccioli, G. G., Hu, S. S.-J., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 441
Self-citationThe emerging functions of endocannabinoid signaling during CNS development
Harkany, T., Guzmán, M., Galve-Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.004 · Cited by 432
Self-citationBuilding a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
Self-citationKearn, C. S., Blake-Palmer, K., Daniel, E., Mackie, K., & Glass, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006882 · Cited by 359
Self-citationLeung, D., Saghatelian, A., Simon, G. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi060163l · Cited by 350
The endogenous cannabinoid system and brain development
Fernández-Ruiz, J., Berrendero, F., Hernández, M. L., & Ramos, J. A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01491-5 · Cited by 347
Lauckner, J. E., Hille, B., & Mackie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509588102 · Cited by 331
Self-citationEndocannabinoid signaling controls pyramidal cell specification and long-range axon patterning
Mulder, J., Aguado, T., Keimpema, E., Barabás, K., Ballester Rosado, C. J., Nguyen, L., Monory, K., Marsicano, G., Di Marzo, V., Hurd, Y. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803545105 · Cited by 327
Self-citationBodor, Á. L., Katona, I., Nyíri, G., Mackie, K., Ledent, C., Hájos, N., & Freund, T. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0442-05.2005 · Cited by 325
Self-citationPregnenolone Can Protect the Brain from Cannabis Intoxication
Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, G. L., Panin, F., Cathala, A., et al. (2014) · Science · doi:10.1126/science.1243985 · Cited by 319
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids
Bacci, A., Huguenard, J. R., & Prince, D. A. (2004) · Nature · doi:10.1038/nature02913 · Cited by 306
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Endocannabinoid-Mediated Metaplasticity in the Hippocampus
Chevaleyre, V., & Castillo, P. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.036 · Cited by 302
Davies, C., Segre, G., Estradé, A., Radua, J., De Micheli, A., Provenzani, U., Oliver, D., Salazar de Pablo, G., Ramella-Cravaro, V., Besozzi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30057-2 · Cited by 301
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
Berrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V., & Fern�ndez-Ruiz, J. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990901)33:3<181::aid-syn3>3.0.co;2-r · Cited by 289
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Jung, K.-M., Sepers, M., Henstridge, C. M., Lassalle, O., Neuhofer, D., Martin, H., Ginger, M., Frick, A., DiPatrizio, N. V., Mackie, K., et al. (2012) · Nature Communications · doi:10.1038/ncomms2045 · Cited by 280
Self-citationAtwood, B. K., Huffman, J., Straiker, A., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 262
Self-citationEndocannabinoid-mediated retrograde modulation of synaptic transmission
Ohno-Shosaku, T., & Kano, M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.017 · Cited by 243
Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A., & Ranganathan, M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.209 · Cited by 238
Mato, S., Del Olmo, E., & Pazos, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02599.x · Cited by 234
Robo1 and Robo2 Cooperate to Control the Guidance of Major Axonal Tracts in the Mammalian Forebrain
López-Bendito, G., Flames, N., Ma, L., Fouquet, C., Di Meglio, T., Chedotal, A., Tessier-Lavigne, M., & Marín, O. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4605-06.2007 · Cited by 231
Ellis, J., Pediani, J. D., Canals, M., Milasta, S., & Milligan, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602494200 · Cited by 225
Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206
Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones
Straiker, A., & Mackie, K. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.091918 · Cited by 201
Self-citationWu, C.-S., Jew, C. P., & Lu, H.-C. (2011) · Future Neurology · doi:10.2217/fnl.11.27 · Cited by 190
Self-citationCannabinoid Control of Learning and Memory through HCN Channels
Maroso, M., Szabo, G. G., Kim, H. K., Alexander, A., Bui, A. D., Lee, S.-H., Lutz, B., & Soltesz, I. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.023 · Cited by 189
The major central endocannabinoid directly acts at GABAAreceptors
Sigel, E., Baur, R., Rácz, I., Marazzi, J., Smart, T. G., Zimmer, A., & Gertsch, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113444108 · Cited by 186
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Fan, P. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.2.907 · Cited by 186
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S.-J., & Mackie, K. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 174
Self-citationSolowij, N., Broyd, S., Greenwood, L.-M., van Hell, H., Martelozzo, D., Rueb, K., Todd, J., Liu, Z., Galettis, P., Martin, J., et al. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00978-2 · Cited by 174
Jung, K.-M., Astarita, G., Zhu, C., Wallace, M., Mackie, K., & Piomelli, D. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037796 · Cited by 170
Self-citationAn Update on Non-CB 1 , Non-CB 2 Cannabinoid Related G-Protein-Coupled Receptors
Morales, P., & Reggio, P. H. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0036 · Cited by 168
Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., Bonnet, D., Le Fur, G., & Gorelick, D. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0861-5 · Cited by 167
Inhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum
Kreitzer, A. C., Carter, A. G., & Regehr, W. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00695-5 · Cited by 167
Paria, B. C., & Dey, S. K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00197-3 · Cited by 161
Nyíri, G., Cserép, C., Szabadits, E., MacKie, K., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.026 · Cited by 161
Self-citationCortical HCN channels: Function, trafficking and plasticity
Shah, M. M. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270058 · Cited by 160
Atwood, B. K., Wager‐Miller, J., Haskins, C. P., Straiker, A. J., & Mackie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074013 · Cited by 160
Self-citationPreferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 159
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
Wager‐Miller, J., Westenbroek, R. E., & Mackie, K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00151-2 · Cited by 156
Self-citationEndocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Tanaka, M., Sackett, S., & Zhang, Y. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00087 · Cited by 154
Martini, L., Waldhoer, M., Pusch, M., Kharazia, V., Fong, J. C., Lee, J. H., Freissmuth, C., & Whistler, J. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-7132com · Cited by 152
Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes
Chicca, A., Marazzi, J., Nicolussi, S., & Gertsch, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373241 · Cited by 148
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Khajehali, E., Malone, D. T., Glass, M., Sexton, P. M., Christopoulos, A., & Leach, K. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099192 · Cited by 146
Wu, C., Zhu, J., Wager‐Miller, J., Wang, S., O’Leary, D. D. M., Monory, K., Lutz, B., Mackie, K., & Lu, H. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07337.x · Cited by 143
Self-citationPrenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone
Frau, R., Miczán, V., Traccis, F., Aroni, S., Pongor, C., Saba, P., Serra, V., Sagheddu, C., Fanni, S., Congiu, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0512-2 · Cited by 136
Niehaus, J. L., Liu, Y., Wallis, K. T., Egertová, M., Bhartur, S. G., Mukhopadhyay, S., Shi, S., He, H., Selley, D. E., Howlett, A. C., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039263 · Cited by 131
Endocannabinoid Transport Revisited
Nicolussi, S., & Gertsch, J. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.011 · Cited by 130
Wiring and firing neuronal networks: endocannabinoids take center stage
Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 126
Self-citationEndocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases
Urquhart, P., Nicolaou, A., & Woodward, D. F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.015 · Cited by 125
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 123
Self-citationLeishman, E., Mackie, K., Luquet, S. H., & Bradshaw, H. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.003 · Cited by 122
Self-citationMinichino, A., Senior, M., Brondino, N., Zhang, S. H., Godlewska, B. R., Burnet, P. W. J., Cipriani, A., & Lennox, B. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0970 · Cited by 121
Nyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
Endocannabinoids and the Immune System in Health and Disease
Cabral, G. A., Ferreira, G. A., & Jamerson, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_6 · Cited by 119
Habayeb, O. M. H., Taylor, A. H., Bell, S. C., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1799 · Cited by 118
Viader, A., Ogasawara, D., Joslyn, C. M., Sánchez-Alavez, M., Mori, S., Nguyen, W., Conti, B., & Cravatt, B. F. (2016) · eLife · doi:10.7554/elife.12345 · Cited by 117
Keimpema, E., Barabás, K., Morozov, Y. M., Tortoriello, G., Torii, M., Cameron, G. A., Yanagawa, Y., Watanabe, M., Mackie, K., & Harkany, T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2126-10.2010 · Cited by 115
Self-citationAtwood, B. K., Lee, D., Straiker, A. J., Widlanski, T. S., & Mackie, K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.066 · Cited by 114
Self-citationVitalis, T., Lainé, J., Simon, A., Roland, A. B., Leterrier, C., & Lenkei, Z. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06484.x · Cited by 109
Identification of a novel family of G protein‐coupled receptor associated sorting proteins
Simonin, F., Karcher, P., Boeuf, J., Matifas, A., & Kieffer, B. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02411.x · Cited by 108
A Molecular Basis of Analgesic Tolerance to Cannabinoids
Tappe‐Theodor, A., Agarwal, N., Katona, I., Rubino, T., Martini, L., Swiercz, J. M., Mackie, K., Monyer, H., Parolaro, D., Whistler, J. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5648-06.2007 · Cited by 106
Self-citationAdermark, L., & Lovinger, D. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706873104 · Cited by 104
Hoffman, A. F., Laaris, N., Kawamura, M., Masino, S. A., & Lupica, C. R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4920-09.2010 · Cited by 104
Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth
Roland, A. B., Ricobaraza, A., Carrel, D., Jordan, B. M., Rico, F., Simon, A., Humbert‐Claude, M., Ferrier, J., McFadden, M. H., Scheuring, S., et al. (2014) · eLife · doi:10.7554/elife.03159 · Cited by 102
Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance
Argaw, A., Duff, G., Zabouri, N., Cécyre, B., Chainé, N., Cherif, H., Tea, N., Lutz, B., Ptito, M., & Bouchard, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4134-09.2011 · Cited by 102
Kenakin, T. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108787 · Cited by 102
Structural insight into Slit–Robo signalling
Hohenester, E. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360251 · Cited by 101
Luk, T., Jin, W., Zvonok, A. M., Lu, D., Lin, X., Chavkin, C., Makriyannis, A., & Mackie, K. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705792 · Cited by 99
Self-citationIn vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
de Lago, E., Ligresti, A., Ortar, G., Morera, E., Cabranes, A., Pryce, G., Bifulco, M., Baker, D., Fernández‐Ruíz, J., & Marzo, V. D. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.027 · Cited by 98
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling
Alpár, A., Tortoriello, G., Calvigioni, D., Niphakis, M. J., Milenkovic, I., Bakker, J., Cameron, G. A., Hanics, J., Morris, C. V., Fuzik, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5421 · Cited by 96
Bushlin, I., Gupta, A., Stockton, S. D., Miller, L. K., & Devi, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049789 · Cited by 95
The Multiple Waves of Cannabinoid 1 Receptor Signaling
Nogueras‐Ortiz, C. J., & Yudowski, G. A. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104539 · Cited by 93
Díaz-Alonso, J., Aguado, T., Wu, C., Palazuelos, J., Hofmann, C., Garcez, P. P., Guillemot, F., Lu, H., Lutz, B., Guzmán, M., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0681-12.2012 · Cited by 91
Self-citationGlycine Receptors in CNS Neurons as a Target for Nonretrograde Action of Cannabinoids
Lozovaya, N., Yatsenko, N., Beketov, A., Tsintsadze, T. S., & Burnashev, N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0977-05.2005 · Cited by 91
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Straiker, A. J., Dvořáková, M., Zimmowitch, A., & Mackie, K. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.111864 · Cited by 90
Self-citationReceptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons
Rozenfeld, R., Bushlin, I., Gomes, I., Tzavaras, N., Gupta, A., Neves, S. R., Battini, L., Gusella, G. L., Lachmann, A., Ma’ayan, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029239 · Cited by 87
Marzo, V. D., PETROCELLIS, L. D., Bisogno, T., & Melck, D. J. (1999) · Lipids · doi:10.1007/bf02562332 · Cited by 87
Kohnz, R. A., & Nomura, D. K. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00047a · Cited by 86
Control of glutamate release by complexes of adenosine and cannabinoid receptors
Köfalvi, A., Moreno, E., Cordomí, A., Cai, N.-S., Fernández‐Dueñas, V., Ferreira, S. G., Guixà-González, R., Sánchez‐Soto, M., Yano, H., Casadó-Anguera, V., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-0739-0 · Cited by 86
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice
Busquets-García, A., Gómez, E. S., Redon, B., Mackenbach, Y., Vallée, M., Chaouloff, F., Varilh, M., Ferreira, G., Piazza, P.-V., & Marsicano, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.4 · Cited by 84
Actions and Regulation of Ionotropic Cannabinoid Receptors
PETROCELLIS, L. D., Nabissi, M., Santoni, G., & Ligresti, A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.001 · Cited by 83
Njoo, C., Agarwal, N. K., Lutz, B., & Kuner, R. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002286 · Cited by 80
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Przybyla, J. A., & Watts, V. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162701 · Cited by 73
Psychosis and synthetic cannabinoids
Deng, H., Verrico, C. D., Kosten, T. R., & Nielsen, D. A. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.012 · Cited by 73
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Spiller, K. J., Bi, G., He, Y., Galaj, E., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14625 · Cited by 72
Ludányi, A., Hu, S. S. J., Yamazaki, M., Tanimura, A., Piomelli, D., Watanabe, M., Kano, M., Sakimura, K., Maglóczky, Z., Mackie, K., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.062 · Cited by 68
Self-citationde Lago, E., Fernández‐Ruíz, J., Ortega‐Gutiérrez, S., Viso, A., López-Rodríguez, M. L., & Ramos, J. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01996-9 · Cited by 67
What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research
Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716645288 · Cited by 67
Jing, M., Zhang, Y., Wang, H., & Li, Y. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14855 · Cited by 58
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
Smith, T. H., Blume, L. C., Straiker, A. J., Cox, J. O., David, B. G., McVoy, J. R. S., Sayers, K. W., Poklis, J. L., Abdullah, R. A., Egertová, M., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096495 · Cited by 56
Self-citationHohmann, U., & Dehghani, F. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0015 · Cited by 54
Ganesh, S., Cortes-Briones, J., Ranganathan, M., Radhakrishnan, R., Skosnik, P. D., & D’Souza, D. C. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa031 · Cited by 47
Hájková, A., Techlovská, Š., Dvořáková, M., Chambers, J. N., Kumpošt, J., Hubálková, P., Prézeau, L., & Blahoš, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.008 · Cited by 42
Bidwell, L. C., Mueller, R. L., YorkWilliams, S. L., Hagerty, S. L., Bryan, A. D., & Hutchison, K. E. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0038 · Cited by 40
Saez, T. M. M., Bessone, I. F., Rodriguez, M. S., Alloatti, M., Otero, M. G., Cromberg, L. E., Devoto, V. M. P., Oubiña, G., Sosa, L. J., Buffone, M. G., et al. (2020) · Development · doi:10.1242/dev.184069 · Cited by 34
Anandamide Dysfunction in Prodromal and Established Psychosis
Leweke, F. M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884843 · Cited by 33
The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
Gouvêa, E. S., Filho, A. F. D. S., Ota, V., Mrad, V. C., Gadelha, A., Bressan, R. A., Cordeiro, Q., & Belangero, S. I. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-1969 · Cited by 25
Gamage, T. F., Farquhar, C. E., Lefever, T. W., Thomas, B. F., Nguyen, T., Zhang, Y., & Wiley, J. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.008 · Cited by 23
Lee, S., Jeong, S., Lee, U., & Chang, S. (2019) · Molecular Brain · doi:10.1186/s13041-019-0464-1 · Cited by 23
Mascia, F., Klotz, L., Lerch, J., Ahmed, M. H., Zhang, Y., & Enz, R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14021 · Cited by 20
Reynoso-Moreno, I., Chicca, A., Flores-Soto, M. E., Paredes, J. M. V., & Gertsch, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00180 · Cited by 20
Aspects of Prostaglandin Glycerol Ester Biology
Kingsley, P. J., Rouzer, C. A., Morgan, A., Patel, S., & Marnett, L. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_8 · Cited by 18
Endocannabinoid Analytical Methodologies: Techniques That Drive Discoveries That Drive Techniques
Piscitelli, F., & Bradshaw, H. B. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.003 · Cited by 11
Assay of Endocannabinoid Oxidation by Cyclooxygenase-2
Kudalkar, S. N., Kingsley, P. J., & Marnett, L. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3539-0_21 · Cited by 9
Krohmer, A., Brehm, M., Auwärter, V., & Szabó, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.032 · Cited by 9
Cited by
Consequences of adolescent drug use
Steinfeld, M. R., & Torregrossa, M. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02590-4 · Cited by 237
“The ECS is widespread throughout the central nervous system and is known to play important roles in many cognitive and behavioral processes [84, 85].”
BackgroundRole of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation
van den Hoogen, N. J., Harding, E. K., Davidson, C. E. D., & Trang, T. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.816747 · Cited by 45
Challenges from the field: experiences of first-year hemp farmers in Nebraska
Caldwell, J., Colclasure, B. C., & Granberry, T. (2025) · Renewable Agriculture and Food Systems · doi:10.1017/s1742170524000334 · Cited by 3
Metadata
- Authors
- Lu, H.-C., & Mackie, K.
- Venue
- Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 6
- Issue
- 6
- Pages
- 607-615
- ISSN
- 2451-9022 (ISSN-L)
- OpenAlex
- W3046433489
- Cited by
- 491
- References
- 144
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.